75 related articles for article (PubMed ID: 31602824)
1. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Campbell K; Kao PC; Naranjo A; Kamijo T; Ramanujachar R; London WB; DuBois SG
Pediatr Blood Cancer; 2023 Feb; 70(2):e30054. PubMed ID: 36316811
[TBL] [Abstract][Full Text] [Related]
2. Stage 4N neuroblastoma before and during the era of anti-G
Kushner BH; LaQuaglia MP; Cardenas FI; Basu EM; Gerstle JT; Kramer K; Roberts SS; Wolden SL; Cheung NV; Modak S
Int J Cancer; 2023 Dec; 153(12):2019-2031. PubMed ID: 37602920
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.
Jamin Y; Tucker ER; Poon E; Popov S; Vaughan L; Boult JK; Webber H; Hallsworth A; Baker LC; Jones C; Koh DM; Pearson AD; Chesler L; Robinson SP
Radiology; 2013 Jan; 266(1):130-40. PubMed ID: 23169794
[TBL] [Abstract][Full Text] [Related]
4. In vivo cisplatin-resistant neuroblastoma metastatic model reveals tumour necrosis factor receptor superfamily member 4 (TNFRSF4) as an independent prognostic factor of survival in neuroblastoma.
Murphy C; Devis-Jauregui L; Struck R; Boloix A; Gallagher C; Gavin C; Cottone F; Fernandez AS; Madden S; Roma J; Segura MF; Piskareva O
PLoS One; 2024; 19(5):e0303643. PubMed ID: 38809883
[TBL] [Abstract][Full Text] [Related]
5. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract][Full Text] [Related]
6. Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma.
Pan LJ; Chen JL; Wu ZX; Wu YM
Technol Cancer Res Treat; 2021; 20():15330338211039132. PubMed ID: 34469238
[TBL] [Abstract][Full Text] [Related]
7. LIN28B: an orchestrator of oncogenic signaling in neuroblastoma.
Schnepp RW; Diskin SJ
Cell Cycle; 2016; 15(6):772-4. PubMed ID: 26743584
[No Abstract] [Full Text] [Related]
8. Experimental verification of a conserved intronic microRNA located in the human TrkC gene with a cell type-dependent apoptotic function.
Dokanehiifard S; Soltani BM; Parsi S; Hosseini F; Javan M; Mowla SJ
Cell Mol Life Sci; 2015 Jul; 72(13):2613-25. PubMed ID: 25772499
[TBL] [Abstract][Full Text] [Related]
9. [Neuroblastoma-like schwannoma of the lung: report of a case].
Hua HJ; Li KD; Zhu Y; Fan QH; Li H
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):492-494. PubMed ID: 38678334
[TBL] [Abstract][Full Text] [Related]
10. Dorsal Amygdala Neurotrophin-3 Decreases Anxious Temperament in Primates.
Fox AS; Souaiaia T; Oler JA; Kovner R; Kim JMH; Nguyen J; French DA; Riedel MK; Fekete EM; Rabska MR; Olsen ME; Brodsky EK; Alexander AL; Block WF; Roseboom PH; Knowles JA; Kalin NH
Biol Psychiatry; 2019 Dec; 86(12):881-889. PubMed ID: 31422797
[TBL] [Abstract][Full Text] [Related]
11. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
Parikh NS; Howard SC; Chantada G; Israels T; Khattab M; Alcasabas P; Lam CG; Faulkner L; Park JR; London WB; Matthay KK;
Pediatr Blood Cancer; 2015 Aug; 62(8):1305-16. PubMed ID: 25810263
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the Neural Environment in Cancer: Exploring the Role of Neural Circuit Players and Potential Therapeutic Strategies.
Nguyen TM; Ngoc DTM; Choi JH; Lee CH
Cells; 2023 Aug; 12(15):. PubMed ID: 37566075
[TBL] [Abstract][Full Text] [Related]
13. Adenocarcinomas of the Lung and Neurotrophin System: A Review.
Ricci A; Salvucci C; Castelli S; Carraturo A; de Vitis C; D'Ascanio M
Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289793
[TBL] [Abstract][Full Text] [Related]
14. Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma.
Seo E; Kim JS; Ma YE; Cho HW; Ju HY; Lee SH; Lee JW; Yoo KH; Sung KW; Koo HH
J Korean Med Sci; 2019 Oct; 34(39):e254. PubMed ID: 31602824
[TBL] [Abstract][Full Text] [Related]
15. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of MYCN amplification in patients with high-risk neuroblastoma.
Lee JW; Son MH; Cho HW; Ma YE; Yoo KH; Sung KW; Koo HH
Pediatr Blood Cancer; 2018 Oct; 65(10):e27257. PubMed ID: 29797634
[TBL] [Abstract][Full Text] [Related]
17. The Neurotrophin Receptor TrkC as a Novel Molecular Target of the Antineuroblastoma Action of Valproic Acid.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360553
[TBL] [Abstract][Full Text] [Related]
18. Targeting neurotrophin-3 and its dependence receptor tyrosine kinase receptor C: a new antitumoral strategy.
Tauszig-Delamasure S; Bouzas-Rodriguez J
Expert Opin Ther Targets; 2011 Jul; 15(7):847-58. PubMed ID: 21473736
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.
Bordow SB; Norris MD; Haber PS; Marshall GM; Haber M
J Clin Oncol; 1998 Oct; 16(10):3286-94. PubMed ID: 9779703
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
